Aytu BiopharmaAYTU
13F holders, Q2 2024 (June 30)At the end of Q2 2024, 27 institutions reported holding Aytu Biopharma Inc. (AYTU) in their 13F filings, unchanged from Q1 2024. 3 opened new positions and 3 sold out. The largest holders were Nantahala Capital Management, LLC ($3.2M), Stonepine Capital Management, LLC ($1.4M) and Armistice Capital, LLC ($736K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Aytu Biopharma Inc.
- CUSIP
- 054754858
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $736K |
| Exits | 3 | $42K |
All 13F filers, Q1 2024 → Q2 2024: 274,734 shares bought and 16,423 shares sold, net +258,311 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Nantahala Capital Management, LLC | 0.32% | No change | 1,086,812 | $3.2M |
| Stonepine Capital Management, LLC | 1.26% | No change | 472,469 | $1.4M |
| Armistice Capital, LLC | 0.02% | New | 252,000 | $736K |
| Renaissance Technologies | 0.00% | Add +3.9% | 74,123 | $216K |
| Geode Capital Management, LLC | 0.00% | Add +3.9% | 35,919 | $105K |
| Vanguard Group Inc. | 0.00% | No change | 27,888 | $81K |
| Dimensional Fund Advisors LP | 0.00% | Add +54.5% | 23,551 | $69K |
| BlackRock Inc. | 0.00% | No change | 22,793 | $67K |
| Citadel Advisors | 0.00% | Add +79.1% | 21,810 | $63K |
| Northern Trust Corp. | 0.00% | Reduce -0.1% | 14,557 | $43K |
| Acadian Asset Management LLC | 0.00% | No change | 14,622 | $41K |
| Royal Bank of Canada | 0.00% | Add +21.3% | 3,285 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -35.2% | 1,962 | $6K |
| JPMorgan Chase & Co. | 0.00% | Reduce -12.9% | 540 | $2K |
| Morgan Stanley | 0.00% | Reduce -58.5% | 440 | $1K |
| UBS Group AG | 0.00% | Reduce -70.0% | 308 | $899 |
| Osaic Holdings, Inc. | 0.00% | No change | 300 | $876 |
| Wells Fargo & Company | 0.00% | Reduce -24.4% | 124 | $362 |
| Bank of America Corp. | 0.00% | Add +84.0% | 92 | $269 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 83 | $242 |
| Group One Trading LLC | 0.00% | No change | 37 | $108 |
| NewEdge Advisors, LLC | 0.00% | No change | 21 | $61 |
| Huntington National Bank | 0.00% | No change | 20 | $58 |
| US Bancorp \de | 0.00% | New | 9 | $26 |
| SJS Investment Consulting Inc. | 0.00% | New | 5 | $15 |
| CarsonAllaria Wealth Management, Ltd. | 0.00% | No change | 5 | $15 |
| Tsfg, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is AYTU's weight in each manager's 13F, not the share of Aytu Biopharma Inc. the manager owns.